BIT
KERX

BlackRock Institutional Trust’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

BlackRock Institutional Trust’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$15.4M Buy
2,620,238
+31,625
+1% +$173K ﹤0.01% 2151
2016
Q3 		$13.7M Buy
2,588,613
+175,601
+7% +$947K ﹤0.01% 2134
2016
Q2 		$16M Sell
2,413,012
-214,462
-8% -$1.2M ﹤0.01% 1993
2016
Q1 		$12.3M Buy
2,627,474
+4,057
+0.2% +$16.2K ﹤0.01% 2134
2015
Q4 		$13.2M Buy
2,623,417
+76,006
+3% +$361K ﹤0.01% 2140
2015
Q3 		$8.97M Buy
2,547,411
+60,599
+2% +$406K ﹤0.01% 2364
2015
Q2 		$24.8M Sell
2,486,812
-125,582
-5% -$1.35M ﹤0.01% 1772
2015
Q1 		$33.3M Buy
2,612,394
+193,055
+8% +$2.48M 0.01% 1590
2014
Q4 		$34.2M Sell
2,419,339
-121,588
-5% -$1.88M 0.01% 1551
2014
Q3 		$34.9M Sell
2,540,927
-13,084
-0.5% -$200K 0.01% 1505
2014
Q2 		$39.3M Sell
2,554,011
-6,449
-0.3% -$91.4K 0.01% 1488
2014
Q1 		$43.6M Buy
2,560,460
+166,953
+7% +$2.52M 0.01% 1386
2013
Q4 		$31M Sell
2,393,507
-40,958
-2% -$489K 0.01% 1606
2013
Q3 		$24.6M Buy
2,434,465
+150,572
+7% +$1.34M ﹤0.01% 1707
2013
Q2 		$17.1M Buy
+2,283,893
New +$17.8M ﹤0.01% 1925

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

BlackRock Institutional Trust's KERX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Keryx Biopharmaceuticals Inc (KERX) stake by 1.2% in Q4 2016, buying an estimated $173K and bringing the position to 2,620,238 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2151.

BlackRock Institutional Trust first reported a position in KERX in Q2 2013 and has held it in 15 quarters since. The position peaked at $43.6M in Q1 2014. 123 funds tracked by Wall St. Rank hold KERX as of Q4 2016.

  • BlackRock Institutional Trust held 2,620,238 shares of Keryx Biopharmaceuticals Inc worth $15.4M as of Q4 2016.
  • BlackRock Institutional Trust bought 31,625 Keryx Biopharmaceuticals Inc shares in Q4 2016, an estimated $173K.
  • Keryx Biopharmaceuticals Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2151 holding.
  • BlackRock Institutional Trust first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Keryx Biopharmaceuticals Inc position peaked at $43.6M in Q1 2014.
  • 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.